Back to Peptides
Weight Loss
Survodutide
Survodutide is a dual GLP-1 and glucagon receptor agonist studied for weight management and metabolic liver disease (MASH/NASH). Its dual mechanism has been investigated for effects on appetite, weight, and hepatic fat.
Weight LossMetabolicLiverSC
Research Benefits
Dual GLP-1 and glucagon receptor activation
Weight-reduction magnitude studied in trials
Investigated for metabolic liver disease (MASH)
Hepatic-fat and cardiometabolic effects explored
Axo's Research Digest
An AI-generated, plain-English overview of what the research explores for Survodutide — and how mature that evidence is.